INTERNATIONAL PATENT: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. FILES APPLICATION FOR "GUT MICROBIOTA FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)"

GENEVA, Dec. 9 -- HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (Jerusalem BioParkHadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem) filed a patent application (PCT/IL2025/050455) for "GUT MICROBIOTA FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)" on May 28, 2025. With publication no. WO/2025/248523, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ASLEH, Rabea (c/o HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.Jerusalem BioParkHadassah Ein Kerem Medical CenterP.O....